Skip to main content
Clinical Trials/TCTR20170425001
TCTR20170425001
Completed
未知

Effect of combined contraceptive pill on immune cell of ovarian endometriotic tissue

Department of Obstetrics and Gynecology, Faculty of Medicine, Ramathibodi Hospital0 sites44 target enrollmentApril 25, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
Patients with ovarian endometriotic cyst Combined oral contraceptive pill
Sponsor
Department of Obstetrics and Gynecology, Faculty of Medicine, Ramathibodi Hospital
Enrollment
44
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 25, 2017
End Date
August 1, 2017
Last Updated
last year
Study Type
Observational
Sex
Female

Investigators

Sponsor
Department of Obstetrics and Gynecology, Faculty of Medicine, Ramathibodi Hospital

Eligibility Criteria

Inclusion Criteria

  • 1\.Healthy female subjects age 18\-45 years old.
  • 2\.Subjects who were diagnosed with endometriotic cyst with size equal or more than 3 centimeters.
  • 3\.Subjects who have no previous records of taking any kinds of hormones during 3 months prior to the study and those who were not recieved depot\-medroxyprogesterone acetate (DMPA) or GnRHa within 9 months prior to the study.
  • 4\.Subjects who have no limitations in taking either ethinyl estradiol with Desogestrel.
  • 5\.Subjects who are willing to participate in the study program.

Exclusion Criteria

  • 1\.Subjects with underlying disease that contraindicate to receive ethinyl estradiol and desogestrel such as Cirrhosis, Chronic kidney disease, Coagulopathy, Heart disease and Pulmonary disease.
  • 2\.Subjects who have contraindication to taking either ethinyl estradiol and desogestrel
  • 3\.Subjects who are intolerable to irregularity of menstruation cycle.
  • 4\.Subjects who rejected or withdrew from the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials